Improving Diagnosis in Idiopathic Cytopenia Using Gene Sequencing
Sponsor: Royal Marsden NHS Foundation Trust
This observational or N/A phase trial investigates Cytopenia and is currently ongoing. Royal Marsden NHS Foundation Trust leads this study, which shows 12 recorded versions since 2017 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
12 versions recorded-
Sep 2024 — Present [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Dec 2021 — Jul 2024 [monthly]
Unknown Status
-
Oct 2021 — Dec 2021 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
-
Jan 2021 — Oct 2021 [monthly]
Recruiting
▶ Show 7 earlier versions
-
Nov 2020 — Jan 2021 [monthly]
Recruiting
-
Jun 2018 — Nov 2020 [monthly]
Recruiting
-
May 2018 — Jun 2018 [monthly]
Recruiting
-
Apr 2018 — May 2018 [monthly]
Recruiting
Phase: NA → None
-
Sep 2017 — Apr 2018 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Aug 2017 — Sep 2017 [monthly]
Not Yet Recruiting NA
-
Feb 2017 — Aug 2017 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Royal Marsden NHS Foundation Trust
For direct contact, visit the study record on ClinicalTrials.gov .